Tanmaya Desai
Fund manager Tanmaya Desai: portfolio changes across the 4 schemes AMFI's scheme summary documents name them on, Oct 2026, by share count.
Equity; Hybrid.
4 with AMFI average AUM, July - September 2026; each scheme in full, not split between co-managers. Source: AMFI.
On a scheme named on today, as the fund house files it. Source: AMFI SSD.
People named on at least one of the same schemes.
- ₹6,504 cr
- ₹5,933 cr
- ₹5,565 cr
- ₹640 cr
| Scheme | Fund house | Category | AUM | Role, as filed | Since, as filed | As of |
|---|---|---|---|---|---|---|
| SBI MNC FUND | SBI Mutual Fund | Equity Scheme - Sectoral/ Thematic | ₹6,504 cr | — | 1 Apr 2024 | 3 Nov 2026 |
| SBI Automotive Opportunities Fund | SBI Mutual Fund | Equity Scheme - Sectoral/ Thematic | ₹5,933 cr | Primary Equity | 5 Jun 2024 | 3 Nov 2026 |
| SBI HEALTHCARE OPPORTUNITIES FUND | SBI Mutual Fund | Equity Scheme - Sectoral/ Thematic | ₹5,565 cr | — | 27 Jun 2011 | 3 Nov 2026 |
| SBI Balanced Hybrid Fund | SBI Mutual Fund | Hybrid Schemes - Balanced Hybrid Fund | ₹640 cr | Fund Manager - Equity | 31 Aug 2025 | 3 Nov 2026 |
From each scheme's summary document on AMFI's site (scheme details), as it stood on the date shown. How to read
Named on the same scheme's summary document; the number is how many schemes they share. Source: AMFI SSD.
- ₹935 cr
- ₹882 cr
- ₹682 cr
- ₹579 cr
- ₹524 cr
- ₹470 cr
- ₹403 cr
- ₹373 cr
- ₹338 cr
- ₹323 cr
| Ticker | Company | Value | % of equity held | Schemes holding |
|---|---|---|---|---|
| DIVISLAB | Divi's Laboratories Limited | ₹935 cr | 5.0 % | 3 |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹882 cr | 4.7 % | 3 |
| M&M | Mahindra & Mahindra Limited | ₹682 cr | 3.7 % | 1 |
| SONACOMS | Sona BLW Precision Forgings Limited | ₹579 cr | 3.1 % | 2 |
| BOSCHLTD | Bosch Limited | ₹524 cr | 2.8 % | 3 |
| MOTHERSON | Samvardhana Motherson International Limited | ₹470 cr | 2.5 % | 2 |
| CIPLA | Cipla Limited | ₹403 cr | 2.2 % | 2 |
| EICHERMOT | Eicher Motors Limited | ₹373 cr | 2.0 % | 2 |
| ANTHEM | Anthem Biosciences Limited | ₹338 cr | 1.8 % | 2 |
| AUROPHARMA | Aurobindo Pharma Limited | ₹323 cr | 1.7 % | 2 |
| AETHER | Aether Industries Limited | ₹315 cr | 1.7 % | 2 |
| CUMMINSIND | Cummins India Limited | ₹312 cr | 1.7 % | 1 |
| TVSMOTOR | TVS Motor Company Limited | ₹302 cr | 1.6 % | 1 |
| MAXHEALTH | Max Healthcare Institute Limited | ₹301 cr | 1.6 % | 1 |
| ACUTAAS | Acutaas Chemicals Limited | ₹300 cr | 1.6 % | 1 |
The 15 largest holdings by market value, summed over the schemes this manager is named on today.
Every stock held by 2 or more of this manager's schemes today, whatever its value — not limited to the largest-holdings list above.
| Scheme | Start, as filed | End | Measured | Scheme return | Category average | Schemes averaged |
|---|---|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND Equity Scheme - Sectoral/ Thematic | 27 Jun 2011 | still named | No return shown: no NAV near the start date | |||
| SBI MNC FUND Equity Scheme - Sectoral/ Thematic | 1 Apr 2024 | still named | 28 Mar 2024 to 20 Nov 2026 | +8.08 % a year | +9.95 % a year | 133 |
| SBI Automotive Opportunities Fund Equity Scheme - Sectoral/ Thematic | 5 Jun 2024 | still named | 12 Jun 2024 to 20 Nov 2026 | +14.02 % a year | +8.26 % a year | 138 |
| SBI Balanced Hybrid Fund Hybrid Schemes - Balanced Hybrid Fund | 31 Aug 2025 | still named | No return shown: no NAV near the start date | |||
Each scheme's direct-growth return over the dates filed for this manager, next to its category's average. Returns and averages are computed by this site from AMFI NAVs; they are not the fund house's figures. Past performance may not be sustained in future.
| Month | Schemes with a change | Stocks added | Stocks cut | Bought | Sold | Net |
|---|---|---|---|---|---|---|
| Oct 2026 | 4 | 40 | 18 | ₹1,290 cr | ₹649 cr | +₹640 cr |
| Sep 2026 | 4 | 40 | 20 | ₹1,267 cr | ₹380 cr | +₹888 cr |
| Aug 2026 | 3 | 26 | 23 | ₹1,243 cr | ₹755 cr | +₹487 cr |
| Jul 2026 | 3 | 19 | 27 | ₹996 cr | ₹757 cr | +₹238 cr |
| Jun 2026 | 3 | 14 | 21 | ₹781 cr | ₹523 cr | +₹258 cr |
| May 2026 | 3 | 10 | 33 | ₹891 cr | ₹961 cr | −₹69.8 cr |
| Apr 2026 | 3 | 11 | 34 | ₹495 cr | ₹652 cr | −₹157 cr |
| Mar 2026 | 3 | 19 | 30 | ₹940 cr | ₹563 cr | +₹376 cr |
| Feb 2026 | 3 | 16 | 24 | ₹684 cr | ₹1,037 cr | −₹353 cr |
| Jan 2026 | 3 | 17 | 24 | ₹1,126 cr | ₹1,297 cr | −₹171 cr |
| Dec 2025 | 3 | 13 | 19 | ₹499 cr | ₹615 cr | −₹116 cr |
| Nov 2025 | 3 | 6 | 18 | ₹435 cr | ₹530 cr | −₹95.0 cr |
Across the schemes this manager is named on today, by share count.
Changes seen in AMFI's documents
since 29 Sep 2026
Changes on this manager's schemes, by the date AMFI's document first showed them.
Added 40
40 stocks · largest 15 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| PARASHLTH | 2 | +₹183 cr | — |
| MAXHEALTH | 1 | +₹94.7 cr | ₹860.00 ▼ −25.1% |
| SCHAEFFLER | 2 | +₹92.9 cr | ₹3,574.00 ▼ −11.1% |
| GLAND | 1 | +₹84.5 cr | ₹3,095.90 ▲ +60.5% |
| PERSISTENT | 2 | +₹64.3 cr | ₹6,048.00 ▲ +2.2% |
| MOTHERSON | 1 | +₹62.6 cr | ₹156.50 ▲ +48.5% |
| BONFIG | 1 | +₹62.5 cr | — |
| MANIPALHOS | 1 | +₹60.2 cr | ₹669.15 ▼ −12.3% |
| EICHERMOT | 1 | +₹57.8 cr | ₹7,220.00 ▲ +3.0% |
| SOLARINDS | 1 | +₹56.4 cr | ₹18,800.00 ▲ +35.5% |
| INE867C01010 | 1 | +₹49.2 cr | — |
| CRAFTSMAN | 1 | +₹30.8 cr | ₹10,271.00 ▲ +53.8% |
| DIVISLAB | 2 | +₹30.3 cr | ₹9,780.00 ▲ +45.1% |
| ZYDUSLIFE | 1 | +₹28.6 cr | ₹1,245.50 ▲ +27.8% |
| CUMMINSIND | 1 | +₹26.7 cr | ₹4,452.60 ▲ +2.5% |
Cut 18
18 stocks · largest 15 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| MARUTI | 2 | −₹108 cr | ₹11,397.00 ▼ −29.6% |
| BRITANNIA | 1 | −₹69.6 cr | ₹4,640.00 ▼ −20.5% |
| HINDUNILVR | 1 | −₹67.1 cr | ₹1,864.60 ▼ −24.4% |
| ACUTAAS | 1 | −₹60.1 cr | ₹4,003.60 ▲ +131.7% |
| BHARATFORG | 2 | −₹51.6 cr | ₹1,720.00 ▲ +29.8% |
| AUROPHARMA | 2 | −₹47.1 cr | ₹1,681.40 ▲ +47.6% |
| BAJAJ-AUTO | 1 | −₹43.5 cr | ₹10,350.00 ▲ +16.4% |
| RAINBOW | 1 | −₹39.4 cr | ₹1,218.70 ▼ −11.0% |
| HYUNDAI | 2 | −₹36.3 cr | ₹1,911.00 ▼ −21.6% |
| M&M | 1 | −₹28.4 cr | ₹2,840.30 ▼ −18.6% |
| MANKIND | 1 | −₹24.9 cr | ₹2,492.80 ▲ +4.6% |
| PRIVISCL | 1 | −₹23.2 cr | ₹3,218.10 ▲ +10.8% |
| GRINDWELL | 1 | −₹18.8 cr | ₹1,878.60 ▲ +11.2% |
| NESTLEIND | 1 | −₹11.7 cr | ₹1,167.00 ▼ −8.2% |
| AJANTPHARM | 1 | −₹6.9 cr | ₹3,508.80 ▲ +42.3% |
Each scheme's change in shares at its month-end price, summed over this manager's schemes, Oct 2026.
Questions about Tanmaya Desai
from the figures on this pageWhat stocks are in Tanmaya Desai's portfolio?
The 4 schemes Tanmaya Desai manages held 112 stocks worth ₹18,644 cr at Oct 2026 end. Largest: Divi's Laboratories 5.0 %, Sun Pharmaceutical Industries 4.7 %, Mahindra & Mahindra 3.7 %, Sona BLW Precision Forgings 3.1 %, Bosch 2.8 %. Divi's Laboratories mutual fund holdings · Sun Pharmaceutical Industries mutual fund holdings · Mahindra & Mahindra mutual fund holdings
Which stocks did Tanmaya Desai buy and sell in Oct 2026?
In Oct 2026, Tanmaya Desai's schemes added to 40 stocks, largest Paras Healthcare (PARASHLTH), Max Healthcare Institute (MAXHEALTH), Schaeffler India (SCHAEFFLER); cut 18, largest Maruti Suzuki India (MARUTI), Britannia Industries (BRITANNIA), Hindustan Unilever (HINDUNILVR), by value at month-end prices.
Which mutual fund schemes does Tanmaya Desai manage?
AMFI's scheme summary documents name Tanmaya Desai (SBI Mutual Fund) for 4 schemes: SBI MNC FUND, SBI Automotive Opportunities Fund, SBI HEALTHCARE OPPORTUNITIES FUND, SBI Balanced Hybrid Fund. SBI MNC FUND portfolio · SBI Automotive Opportunities Fund portfolio · SBI HEALTHCARE OPPORTUNITIES FUND portfolio